Company page

Genelux Corporation

Genelux Corporation, trading under the ticker GNLX, is a public company based in the United States with a market capitalization of approximately $129.6 million. The company focuses on developing innovative therapies for cancer treatment. Genelux aims to advance its proprietary technologies to improve patient outcomes in oncology.